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Cytotoxic necrotizing factor type 2 produced by virulent Escherichia
coli modifies the small GTP-binding proteins Rho involved in
assembly of actin stress fibers
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humans and animals with diarrhea or extraintestinal infections produce CNF1 or CNF2 (1-6). Second, experimental
infections of neonatal calves (18) and pigs (19) with CNF1- or
CNF2-producing strains suggest that CNF1 and CNF2 contribute to the pathogenesis of colibacillosis. Third, CNFs are
potent toxins that cause tissue damage and death of the
animal host (20). Fourth, CNF1 can trigger the entry of
noninvasive bacteria into HEp-2 human epidermoid carcinoma cells through phagosome-like organelles (21). This
induction of phagocytic behavior in human epithelial cells is
associated with the capacity of CNF1 to induce F-actin
assembly (22).
In this paper, we present the cloning and sequence analysis
of the gene encoding CNF2 and describe experiments which
led to the identification of its target in the mammalian cell.tt

Cytotoxic necrotizing factor type 2 (CNF2)
i
produced by Escherichia coil strains isolated from

ABSTRACT

inf
s I a dermonecrotic toxin Of 110
and eitraintetnal
kDa. We cloned the CNF2 gene fom a large pasmd carried
by an Escherichia co strain ated from a lamb with septicemla. Hydropathy analysis of the deduced amino acid sequence revealed a largey hydropic protein with two potential hydrophobic transmembrane domains. The N-terminal
halfofCNF2 showed sriking homology (27% Identity and 80%
conserved residues) to the N-te l portion of Pasteurella
multocida toxin. Methylaminprotection experiments and immunofluorescence studies ggesed that CNF2 enters the
cytosol of the target cell throgh an acidic compartmnt and
i of actin into stress fibers. Since the
induces the re
formation of stress fibers In eukaryotic cells involves Rho
proteins, we radiolabeled these small GTP-bindlug proteins
from CNF2-treated and control cells with a Rho-specific ADPribosyltransferase. The P3PJADP-ribosylated Rho proteins
frm CNF2-treated cells migrated sightly more slowly in
SDS/PAGE than did the labeled proteins from the control
cells. This shift In moblllty of Rho proteins in SDS/PAGE was
also observed when CNF2 and the RhoA protein were coexpressed inE. colt. We propose that Rho proteins are the targets
a
cells.
of CNF2 in m

MATERIALS AND METHODS
Clonug and Sequenclng of cnf2. DNA manipulations were
carried out by standard procedures (23). Vir plasmid DNA
was purified from E. coli 711(pVir) (15), partially digested by
Sau3Al, and ligated to BamHI-digested pILL570 plasmid
DNA (24). E. coli MC1061 (23) transformed with recombinant
plasmids was screened for the production of CNF2 by the cell
cytotoxic assay (4), the rabbit skin test (2), and the mouse
footpad test (11). TnS mutagenesis of pEOAL6 was conducted with the F',,1141ac::TnS plasmid (25). Subclones of
pEOAL6 and pEOAL10 were constructed in plasmid vectors
pBluescript II SK(+) (Stratagene) and pK184 (26). The
nucleotide sequence of double-stranded template DNA was
determined as described in the CircumVent thermal cycle
dideoxy DNA sequencing kit (New England Biolabs). DNA
and peptide sequence data were analyzed by the Genetics
Computer Group software package (27). CNF2 secondary
structure was predicted with the program developed by

Certain Escherichia coli strains isolated from humans or
animals with diarrhea or extraintestinal infections produce a
cytotoxic necrotizing factor (CNF) that causes multinucleation in tissue culture cells and necrosis in the rabbit skin
(1-7). Two types of CNF have been described: CNF1,
produced by E. coli strains isolated from humans and animals
(1-6), and CNF2 (first named Vir cytotoxin), produced by E.
coli strains isolated from cows and sheep (2, 4, 7). CNF1 and
CNF2 are similar in size with an apparent molecular mass of
110-115 kDa in SDS/PAGE (8-10) and are immunologically
related (2, 4, 10). However, CNF1 and CNF2 are distinguishable by (i) the specific necrotic activity of CNF2 in mouse
footpads (11), (ii) the different responses of CNF1 and CNF2
in cross-neutralization assays (2, 4, 7), and (Ni) the different
serogroups and other virulence factors associated with the E.
coli strains that produce these toxins (2, 12, 13). In addition,
CNF1 is chromosomally encoded (14), whereas CNF2 is
encoded by F-like plasmids (7) that were initially designated
as Vir plasmids (15-17).
Several lines of evidence support a role for CNF in E. coli
pathogenicity. First, 10o-40 of E. coli strains isolated from

Burkhard and Sander (28).
Radiolabeflug of Rho Proteins by ADP-ribosylation. Swiss
3T3 mouse cells were maintained in Dulbecco's modified
Eagle's medium containing 10%o fetal bovine serum. After a
24-hr incubation with CNF2 extracts, cells were washed
three times with cold phosphate-buffered saline, pooled by
scraping, pelleted by centrifugation, and homogenized by
Abbreviations: CNF, cytotoxic necrotizing factor; PMT, Pasteurella
multocida toxin.
tPresent address: Laboratoire Associ6 de Microbiologie Moldculaire, Institut National de la Recherche Agronomique, Ecole National VWtdrinaire de Toulouse, 31076 Toulouse, France.
**To whom reprint requests should be addressed.
ttThe sequence of cnJ2 presented in this paper has been deposited in
the GenBank data base (accession no. U01097).
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sonication (29). The proteins in the resulting homogenates
were [32P]ADP-ribosylated in vitro with pure Staphylococcus
aureus epidermal cell differentiation inhibitor (EDIN) (30).
The standard reaction mixture (100 skd) contained 10 ALM
[a-32P]NAD (1000-3000 cpm/pmol), 40 ng of EDIN, and the
cell lysate. After 20 min at 30'C, proteins were precipitated
with 10% (wt/vol) trichloroacetic acid and analyzed by
SDS/12% PAGE. The same techniques were used to ADPribosylate the RhoA protein present in sonic lysates of E. coli
strains carrying pGC-RhoA and pK184 or pGC-RhoA and
pEOSW30. The pGC-RhoA plasmid contains RhoA cDNA
under the control of a tryptophan promoter (31). Samples of
E. coli strains were prepared by sonication of the cells from
a late-logarithmic-phase culture in Luria-Bertani (LB) medium.

RESULTS
Cloning of the DNA Region of pVir Required for CNF2
Production. A common region of 5.15 kb was identified by
comparing the restriction maps of pEOAL6 and pEOAL10,
two subclones from pVir that caused multinucleation of
HEp-2 cells (Fig. 1). E. coli transformed with mutant plasmids containing TnS insertions mapped in this common
region did not produce CNF2 (Fig. 1). Additional evidence
that this 5.15-kb region contained the gene(s) responsible for
multinucleation was obtained by subcloning this region in a
pBluescript II SK(+) vector. First, the 350-bpBgl II fragment
of pEOAL10 was ligated into BamHI-digested pBluescript II
SK(+). The resulting recombinant plasmid was digested with
Xba I/BamHI and ligated to the 4.8-kb Xba I-BamHI fragment from pEOAL6. One such clone, pEOSW20, contained
the correct 5.15-kb insert and expressed CNF2 (Fig. 1).
Identification and Sequence of the Open Reading Frame
(ORF) Encoding CNF2. The region common to the CNF2producing clones was sequenced. An open reading frame
(ORF) of 3045 nucleotides was identified. This ORF was
85.7% identical to the recently sequenced gene encoding
CNF1 (14). The identification of the 3045-bp ORF as cnJ2 was
confirmed by subcloning the Ban I-Hae II DNA fragment
encompassing the ORF and the 112-bp region upstream of the
start codon. This 3332-bp Ban I-Hae II DNA fragment was
digested with mung bean nuclease and ligated into Sma
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I-digested pK184. The resulting clone, pEOSW30 (Fig. 1),
was transformed into E. coli XL1-blue; the lysate of E. coli
XL1-blue(pEOSW30) induced multinucleation of HEp2 cells
and caused necrosis in the mouse footpad and in the rabbit
skin. By contrast, a similarly prepared lysate of control strain
E. coli XL1-blue(pK184) was not toxic in vitro or in vivo (data
not shown). Taken together, these results support our conclusion that the ORF cloned in pEOSW30 is cnJ2.
Analysis of the Deduced Amino Acid Sequence ofCNF2. cnJ2
encodes a protein of 1014 amino acids with a calculated
molecular weight of 114,659. Analysis of the deduced amino
acid sequence of CNF2 revealed an atypical codon usage for
E. coli which reflects the low G+C content of cnJ2 (35.3%).
The hydropathy profile predicted by the program of Kyte and
Doolittle (32) showed that CNF2 was a relatively hydrophilic
protein with two putative hydrophobic transmembrane domains (amino acids 333-372 and 386-409). These two domains were partially overlapped by two predicted a-helices
(amino acids 327-342 and 391-410). Most notably, no classical signal sequence was found in the N-terminal 50 residues
of CNF2. Beside the high homology between CNF2 and
CNF1 (the two toxins shared 85% identical residues and 99%o
conserved residues over 1014 amino acids; Fig. 2), a comparison of the predicted amino acid sequence of CNF2 with
sequences in GenBank (Release 80) revealed that the Pasteurella multocida toxin (PMT) shared 27% identical residues
and 80%o conserved residues over the N-terminal 528 amino
acids of CNF2 (Fig. 3). Similar findings were noticed in the
analysis of the deduced amino acid sequence of CNF1 (14).
We also observed 77% homology between CNF2 amino acids
399-426 and the glucose-binding domain of hexokinase B
from Saccharomyces cerevisiae (35) and 64% homology
between CNF2 amino acids 67-319 and the N terminus of the
epidermin-modifying enzyme EpiB of Staphylococcus epidermidis (33) (data not shown).
Methylamine Protection of HEp-2 Cells from CNF2 Toxicity.
To study the mechanism by which CNF2 enters and reaches
the cytoplasm in HEp-2 cells, various concentrations of
methylamine chloride (pH 7.4) were added to the culture
medium of subconfluent HEp-2 cells. Methylamine is an
agent that increases endosomal and lysosomal pH and
thereby inhibits the processing and translocation of many
toxins into the cell cytoplasm (34). An E. coli XL1-

5.15 kb
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FIG. 1. Restriction maps of various subclones of the Vir plasmid that contain cnJ2. The production of CNF2 after transformation into E.
coli XL1-blue or MC1061 is shown at right. The cloning vector for pEOAL6, pEOAL61, pEOAL62, and pEOAL10 was pILL570. The cloning
vector for pEOSW20 was pBluescript SK II(+). The cloning vector for pEOSW30 was pK184. Arrows indicate the 5' -* 3' orientation of the
IacZ gene in pBluescript SK II(+) and pK184. The restriction sites of relevant endonucleases are indicated: Ba, BamHI; Bg, Bgl II; Bn, Ban
I; C, Cla I; P, Pst I; H, Hae II; X, Xba I.
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1 MNVQWQQKYLLEYNELVSNFPSPERVVSDYIRRCFKTDLPWFSQVDPDNT 50
-GN --------------------------- KN ---------- RI ----A
51 YFIRFSQSRSNSRSYTGWDHLGKYKTGVLTLTQAALINIGYHFDVFDDAN 100
---C---N------------------E--------------R--------

1 MNVQWQQKYLLEYNELVSNFPSPERVVSDYIRRCFKTDLPWFSQVDPDNT 50
1:1 :1:1
11:1:::: ::::
::
::1:
35 NNVKWKEVFINRFGQMMLDTPNPRKIVEKIINEGLEKQG--LKNIDPETT 82
51 YFIRFSQSRSNSRSYTGWDHLGKYKTGVLTLTQAALINI--GYHFDVFDD 98

101 ASAGIYKTSSADMFNEKNEEKMLPSEYLYFLKGCDFSGIYGRFLSDYWSK 150
S-T----- K---V---E----------- H--QK ---A-V--KT -------

83 YFNIFSSSDSSDGNVFHYNSLS----ESYRVTDACLMNIFVERYFDDWDL 128

151 YYDKFKLLLKNYYISSALYLYKNGEIDEYEYNFSISALNRRDNISLFFFD 200
------------------------- L--R -----MN ---- S----- L--201 IYGYYSSDMFVAKNNERVMLFIPGAKKPFLFEKNIADLRISLKNLIKEND 250
-----A--I ----D--DK--------------K-------LT--E---DS-

129 LNSLASNGIYSVGKEGAYYPDHDYGPEYNPVWGPNEQIYHSRVIADILYA 178

251 NKQLLSQHFSLYSRQDGITYAGVNSVLNAIENDGVFNESYFLYSNKRINN 300
KQ--------------- VS--------H------N -----------TLS-

99 AN--ASAGIYKTSSADMFNEKNE------------ EKMLPSEYLY-FLKG 133

134 CDFSGIYGRFLSDYWSKYYDKFKLLLKNYYISSALYLYKNGEIDEYEYNF 183
179 RSVWDEFKKYFMEYWQKYAQLYTEMLSDTFLAMAIQQYTRQTLTDEGFLM 228

301 KDVFDAVAFSVKKRSFSDGDIVIKSNSEAQRDYALTILQTILSMTPIFDV 350
------I-I----------------------------------------I

-RVMLFIPGAKKP 228
184 SISA-LNRRDNISLFFFDIYGYYSSDMFVAKNNE ---

351 AIPEVSVTLGLGI IASSMGISFDQLINGDTYEERRSAIPGLATNAALLGL 400

229 VCNTYYGNKEEVQITLLDIYGYPSTDIICIEQKGLPTPKVILYIPGGTQP 278

VV---- P----- T------------------------------V----

401 SFAIPFLISKAGTNQKILSRYTKHEIRTLNETNIDMFLEEYGINKNSISE 450
-----L------ I--EV--SVINN-G--------- I--K----AED---S

451 TKVLEVELKGSGQHVNIVKLSDEDNKIVAVKGNSLSGIYYEVDIETGYEI 500

229 FLFEKNIADLRISLKNLIKENDNKQLLSQHFSLYSRQDGITYAGVNSVLN 278

279 FVEFLNTDDLKQWIAWHLKDNKHMVRFRKHFSLKQRQEGETFTGIDKALQ 328

-NL-D-K--S -------------Q-- ----- S-----------------

279 AIENDGV--FNESYFLYSNKRINNKDVFDAVAFSVKKRSFSDGDIVIKSN 326

501 SSRRIYRTEYNDKIFWTRGGGLKGGQSFDFESLKLPIFFKDEPYSAVPGS 550
L----------NE-L----P-------HP-----NI-V---------- T-551 SLSFINDDSSLLYPNSTPKLPQPTPEMEIVNYVKRAGNFGERLVTLMRGT 600
P-------------DTN-------S--D------GS-S--D-F------A

329 YIAEESPEWPANKYILYNPTHLETENLFNIMMKRTEQRMLEDSDVQIRSN 378

601 TEEEAWNIARYHTAGGSTEELHEILLGQGPQSSLGFTEYTSNINSADAAS 650
V-S-

327 SEAQRDYALTILQTILSMTPIFDVAIPEVSVTLGLGI IASSMGISFDQLI 376
379 SEATRDYALSLLETFISQLSAIDMLVPAVGIPINFALSATALGLSSDIVV 428
377 NGDTYEERRSAIPGLATNAALLGLSFAIPFLISKAGTNQKILSRYTKHEI 426

651 RRHFLVVIKVQVKYINNNNVSHVNHWAIPDEAPVEVLAVVDRRFNFPEPS 700

429 NGDSYEKRKYGIGSLVQSALFTGINL-IP-VISETAEILSSFSR-TEEDI 475

TPPNISI IHKLLSLRYFKENIESTSRLNLQKLNRGNIDIFKGRGSISSTR

427 RTL--NETNIDMFLEEYGINKNSISETKVLEVELKGSGQHVNIVKLSDED 474

701

---D--T-R----------S----- KS-F---S-----VL----------

750

751 QRAIYPYFESANADEQQPVFFYIKKNRFDDFGYDQYFYNSTVGLNGIPTL 800

476 PAFFTEEQALAQRFEIVEEELHSISPDDPPREITDENLHKIRLVRLNNEN 525

475 NKIVAVKGNSLSGIYYEVDIETGYEISSRRI--YRTEYNDKIFWTRGGGL 522

801 NTYTGEILSDASSLGSTYWKKYNLTNETSIIRVSNSARGANGIKIALEEV 850

526 QPLVVLRRLG-GNKFIRIEPITFQEIKGSLVSEVINPVTNKTYYVSNAKL 574

851 QEGKPVI ITSGNLSGCTTIVARKGGYLYKVHTGTTIPLAGFTSTTGVKKA 900
-----------------------E--I--------KS-------------

523 KGGQSF 528

------PS -------------------------

901 VEVFELLTNNPMPRVEGVMNNDFLVNYLAESFDESLITYSSSEQKIGSKI 950
---L----KE-I------S------D--S-N-ED---------K-PD-Q-

951 TISRDNVSTFPYFLDNIPEKGFGTSVTILVRVDGNVIVKSLSESYSLNVE 1000
--I ------V ---------H----A-V------- V-R---------AD

1001 NSNISVLHVFSKDF* 1015
A-E -----K-----K--

FiG. 2. Similarity between the deduced amino acid sequences
from E. coli CNF2 (this study) and E. coli CNF1 (14). Identical
residues are indicated by dots, conserved residues by plain letters,
and nonconserved residues by boldface letters.

blue(pEOSW30) lysate that contained a CNF2 activity estimated at 4 CD50 (4 times the median cytotoxic dose) was
added to the HEp2 cells treated with methylamine. The
percentage ofmultinucleated cells was measured after a 72-hr
incubation. We observed that the addition of methylamine 1
hr prior to the addition of the toxic extract protected the
HEp-2 cells from CNF2 toxicity in a dose-dependent manner.
Indeed, 5 mM methylamine reduced to 40%o the number of
multinucleated cells as cofnpared with untreated cells, and 10
mM methylamine completely inhibited the multinucleation
effect induced by CNF2 (data not shown). In contrast, no
protective effect was observed when the methylamine (up to
15 mM) was added 2 hr after CNF2 (data not shown). These
findings suggest that acidification of endosomes is required
for the expression of CNF2 cytotoxicity. Similar results have
been observed with PMT (36).
CNF2-Inducd Assembly of F-Actfn. CNF1 mediates actin
assembly in intoxicated cells (22). We speculated therefore
that CNF2 might also cause the reorganization of F-actin,
based on the similar effects of CNF1 and CNF2 in inducing
multinucleation. To test this hypothesis, HEp-2 cells were
incubated for 24 hr with a CNF2-containing extract from E.
coli XL1-blue(pEOSW30) or, as a control, a similarly prepared extract from E. coli XL1-blue(pK184). Cellular F-actin
from extract-treated cells was then stained with fluorescein
isothiocyanate-conjugated phalloidin (21). Lysates of E. coli
XLl-blue(pEOSW30) that contained CNF2 drastically modified the actin cytoskeleton of HEp-2 cells, whereas the
control lysate of XLl-blue(pK184) had no such an effect (Fig.
4). The actin was reorganized into long thick filaments
(classically called stress fibers) in the CNF2-treated cells,

575 LGGSPY 580

FIG. 3. Similarity between the deduced N-terminal amino acid
sequence of E. coli CNF2 and the N terminus of PMT (43, 44). The
GAP program of the Genetics Computer Group package was used to
compare the deduced amino acid sequences of CNF2 (upper line) and
PMT (lower line). Identical residues are indicated by vertical lines
and conserved residues by colons.

whereas the majority of F-actin remained diffuse in the
control-treated cells or untreated cells (data not shown). The
CNF2-induced actin filament reorganization preceded the
multinucleation that was observed 48-72 hr after exposure of
the HEp-2 cells to the toxin. We postulate, as has been
proposed for CNF1 (22), that treatment of HEp-2 cells with
CNF2 causes the reorganization of F-actin, which might
block cytokinesis during mitosis and subsequently lead to the
formation of multinucleated cells in culture.
CNF2-Modlfied Rho Proteins. It has been shown recently
that a possible intracellular target ofCNF1 in eukaryotic cells
could be the small GTP-binding proteins of the Rho family
(37). These proteins regulate the assembly of focal adhesion
and stress fibers in eukaryotic cells (38, 39). To determine
whether CNF2 mediates actin polymerization of intoxicated
cells through these small GTP-binding proteins, we radiolabeled the Rho proteins from lysates of CNF2-treated Swiss
3T3 cells with a Rho-specific ADP-ribosyltransferase produced by Staphylococcus aureus (30). Nearly confluent
Swiss 3T3 cell cultures were incubated for 24 hr with a
CNF2-containing cell extract from E. coli XL1-blue(pEOSW30) or, as a control, a similarly prepared extract
from E. coil XL1-blue(pK184). The radiolabeled Rho proteins from eukaryotic cells treated with CNF2 were shifted
toward higher molecular weight as compared with those from
control cells (Fig. SA). To further demonstrate the role of
CNF2 in the modification ofRho proteins in eukaryotic cells,
we tried to directly reproduce the shift in Rho protein
mobility observed in SDS/PAGE of RhoA protein expressed
in E. coli. For this purpose, we transformed an E. coli strain
carrying a recombinant clone that expresses RhoA with
plasmid pK184 or pEOSW30 and tested the lysates for the
presence of modified RhoA. Both E. coli C600(pK184; pGC-
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similar finding was observed after microinjection of the toxin
into Xenopus oocytes loaded with (32P]NAD (P.B., unpublished data). These preliminary experiments show that the
structural alteration of Rho proteins by CNF2 does not
involve NAD-dependent ADP-ribosylation or ATP-dependent phosphorylation of Rho proteins.

FIG. 4. Fluoresceinated phalloidin-stained actin in HEp2 cells
after 24 hr of incubation with or without CNF2. (Upper
treated with an extract of E. coli XL1-blue(pK184). (Lower) Cells
treated with an extract ofE. coli XL1-blue(pEOSW30) 1 contained
CNF2. (x500.)

Lhat

RhoA) and C600(pEOSW30; pGC-RhoA) prodiuced RhoA,
but only the latter strain produced CNF2. In thiis strain, the
radiolabeled RhoA protein showed an apparent, albeit small
increase in molecular weight as compared to ccontrol cells
(Fig. SB). However, this molecular weight shiftt was reproducibly larger in the eukaryotic cells (Fig. 5A)tthan in the
prokaryotic cells (Fig. 5B). The biochemical 1basis of the
mobility shift of CNF2-modified Rho proteins in SDS/PAGE
remains to be determined. To test the possibilityy that CNF2
could be an ADP-ribosylating enzyme or an AT]P-dependent
t with
protein kinase, we treated Swiss 3T3 cell homojgenates
CNF2
and
extracts
either
[3
partially purified
[a-32P]ATP. SDS/PAGE followed by autoradi ography
3
not reveal any specific 32P-labeled proteins in th
swn). A
cell homogenates treated with CNF2 (data not shown).
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FIG. 5. Autoradiograms of the Rho proteins expiressed by eukaryotic or prokaryotic cells in the presence (+) or albsence (-) of
CNF2. Lysates of eukaryotic or prokaryotic cells were
analyzed. (A) Lysates of Swiss 3T3 cells treated with an extract of
E. coli XL1-blue(pK184) (-) or with an extract of E.
blue(pEOSW30) that contained CNF2 (+). (B) Lysates of control
o E.
coli C600(pK184; pGC-RhoA) (-) and of E. coli C6(
pGC-RhoA) that contained CNF2 (+). Position and siz e (kDa) of the
markers are shown at right.
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DISCUSSION
Two major conclusions about CNF2 production and its
biological properties can be derived from this study. First,
CNF2 in E. coli is encoded by a single structural gene, cnJ2,
and the recombinant CNF2 is fully active in inducing multinucleation in cultured eukaryotic cell lines and in causing
necrosis in both rabbit skin and mouse footpad. Second,
CNF2 is a potent cytotoxin which drastically modifies the
actin cytoskeleton of HEp-2 cells. The capacity of CNF2 to
mediate polymerization of F-actin suggests that this toxin,
like CNF1, may trigger the actin-dependent endocytosis of
bacteria (21). Based on these results and on the incidence of
CNF-producing strains in human and animal infections, we
believe that CNF2 may be an important virulence determinant in E. coli strains that cause enteric and extraintestinal
infections.
The actin cytoskeleton is a key player not only in the
interactions of pathogenic bacteria with mammalian cells but
also in many cellular processes, including cell division and
growth control. Actin assembly in eukaryotic cells has been
shown to involve the Rho proteins (38, 39). This family of
Ras-related proteins is also involved in cell growth regulation
(40) and in the signal transduction pathway linking growth
factor receptors to the assembly of focal adhesions and the
organization of actin into stress fibers (41). In the present
study, we have shown that Rho proteins in CNF2-treated
cells were shifted toward a higher molecular weight in
SDS/PAGE. We were able to reproduce this shift when
CNF2 and RhoA were coexpressed in E. coli. This result
strongly supports a direct interaction between CNF2 and the
Rho proteins and demonstrates that the modification of Rho
proteins by CNF2 does not require prior C-terminal modification and processing by enzymes unique to eukaryotic cells.
The effects of CNF2 on the actin cytoskeleton mimic those
observed when a constitutively activated mutant of RhoA,
I[Val14]RhoA, is microinjected into Swiss 3T3 cells (39). We
propose that CNF2 covalently modifies the structure of Rho
protein in such a way that the modified Rho protein is
functionally
hyperactive
as compared
with itsofnative
form.
This hyperactive
state may
be a reflection
an altered
with its target or with
interaction
of activated
other
accessory
proteinsRho
suchproteins
as the GTPase-activating
proteins and GDP-dissociation inhibitors (42). Although we have
not identified the mechanism of CNF2 action, the amino acid
homology between CNF2 and EpiB, a protein involved in the
posttranslational modification of epidermin (33), may provide
some clues to the nature of the CNF2-induced modification
of Rho proteins.
The mechanism by which CNF2 is delivered to the host cell
during an infection remains unclear. Analysis of the deduced
amino acid sequence of CNF2 showed the absence of a
consensus signal sequence. This result was not surprising
since most of the CNF2 activity was found in the cytoplasm
of the bacteria after 24-hr shaking culture in tryptic soy broth
(TSB) or LB broth (data not shown). However, since laboratory culture conditions do not necessarily reflect the in vivo
environment of the host during an infection, we cannot rule
out the possibility that the toxin is secreted through an
inducible excretion machinery in the in vivo environment.
Alternatively, lysis of some bacteria may release enough
toxin to modify the cytoskeleton of the host cell without
active secretion of CNF2. Indeed, picomolar concentrations
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of CNF1 are sufficient to induce F-actin polymerization (21),
and we have also found that the supernatant of a 24-hr TSB
broth culture from a CNF2-producing strain contains enough
toxin to modify the cytoskeleton of HEp-2 cells (data not
shown).
Although there is no report of a multinucleating effect of
PMT on cultivated cells, the homology observed between the
N-terminal region of CNF2 and the 145-kDa PMT is intriguing for several reasons. First, PMT, which is the primary
virulence determinant of strains of P. multocida that cause
progressive rhinitis in pigs, has no significant homology to
any protein except CNF2 and CNF1 (refs. 14, 43, and 44; this
report). Second, like CNF2, PMT is a nonsecreted protein
without a typical signal sequence (43, 44) that induces dermonecrotic lesions in animals and enters the cytoplasm of
target cells via an acidic compartment (36). Third, PMT is a
potent mitogen that appears to facilitate the coupling of
heterotrimeric GTP-binding protein to phosphatidylinositolspecific phospholipase C which, in turn, stimulates the formation of inositol phosphate (45). This interaction of both
PMT and CNF2 with a GTP-binding protein may indicate a
link between the modes of action of PMT and CNF. Preliminary results indicate that CNF2, like PMT, can induce DNA
synthesis in quiescent cells. Because PMT and CNF2 share
several common characteristics, we propose that the CNF
toxins and PMT are members of a heretofore unrecognized
family of toxins which modify GTP-binding proteins in a
novel way. We believe that PMT and CNF, and functionally
similar proteins yet to be discovered, will provide unique
molecular tools to elucidate cellular and molecular regulatory
mechanisms of eukaryotic cells.
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